CannabisNewsBreaks

FridaySep 27, 2019 2:32 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Focusing on CBD-Based Nutrition, Health Products

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX), through its division CBD Biotech Inc., is concentrating on cannabidiol (CBD)-based nutrition and health products. An article discussing the company reads, “CIIX recently announced that CBD Biotech launched six new products in combination with its long-term strategic plans to expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear Bright. These products are designed to complement the company’s present skincare…

Continue Reading

ThursdaySep 26, 2019 2:49 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Plans to Expand Reach of Distinctive 100% Natural CBD Oil

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) manufactures 100% natural CBD oil using the supercritical CO2 liquid extraction, isolation and micron-filtration process. An article discussing the company reads, “ETST recently filed a 10-K annual report with the SEC that included an outline of the company’s five-year expansion plan for manufacturing and marketing its CBD products (http://cnw.fm/z6FOm). The plan includes information about the company’s strategic preparations to scale up the production of its CBD oil, introduce new products and make its innovative hemp products available worldwide (http://cnw.fm/7gI5w). . . . ‘Our CBD-rich hemp oil does not contain any synthetic cannabinoids and is…

Continue Reading

ThursdaySep 26, 2019 2:42 pm

CBDNewsBreaks – Neutra Corp. (NTRR) Targets Hemp-Based CBD Market

Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, is aiming to participate in the hemp-based CBD market through its recent strategic acquisition of Vivis Corp. A recent article discussing the interview reads, “The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49%, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://cnw.fm/6MJmx). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries. . . . Neutra Corp.’s previously announced acquisition…

Continue Reading

ThursdaySep 26, 2019 10:32 am

CBDNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Chief Marketing Officer Recognized on Forbes CMO Next List

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced that Jann Parish, Chief Marketing Officer, has been named to the Forbes CMO Next list, a list comprised of 50 individuals considered to be leading the way as disruptive chief marketers. Established through qualitative research and editorial industry knowledge, the Forbes list features executives in the top marketing position at their company that push brand and business growth. Through Parish's leadership the company has opened over 130 Seventh Sense CBD shops, expanded Seventh Sense's digital reach, increased sales and margin figures in its Nevada The+Source dispensary business by…

Continue Reading

WednesdaySep 25, 2019 12:45 pm

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently launched its ChrgD+ product, a water-soluble, multispectrum hemp oil in a powdered format powered by the company’s proprietary DehydraTECH(TM) technology for rapid CBD delivery (http://cnw.fm/a3Kr5). An article discussing the company reads, “The rapid biodelivery of CBD through DehydraTECH provides an avenue for safer, less-conspicuous consumption of CBD than inhaling it through smoke or vapor during a critical time when social acceptance of cannabis products is exploding age-old prohibitions but many legislative entities continue to struggle with regulatory issues on behalf of the public welfare. . . .…

Continue Reading

WednesdaySep 25, 2019 12:37 pm

CBDNewsBreaks – VPR Brands LP (VPRB) Gearing Up to Launch Vape Battery Line

VPR Brands (OTCQB: VPRB), a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”), is gearing up to debut a JUST Batteries vape line in connection with its collaboration with Just CBD (http://cnw.fm/P3sKx). An article discussing the company reads, “VPRB has been named the exclusive vendor to design and manufacture vape batteries for JUST Brands. The new line will be known as JUST Batteries and consist of high-quality vaporizer batteries. The line, which will debut in Q3, is designed to complement the JUST CBD prefilled tanks. Additional SKUs are expected to be introduced in…

Continue Reading

ThursdaySep 19, 2019 2:36 pm

CBDNewsBreaks – Neutra Corp. (NTRR) CEO Discusses CBD as Chronic Pain Treatment

Early-stage research and development company Neutra Corp.’s (OTCQB: NTRR) CEO Sydney Jim recently discussed the company’s activities in an interview with NetworkNewsWire (http://cnw.fm/b07SI). A recent article discussing the interview reads, “Jim, a former professional tennis player, emphasized the company’s motivation to help the next generation of athletes with pain management. During the interview, he talks about dealing with pain, not only as a former professional athlete but, on an occasion as recent as last year, when he suffered multiple severe injuries and broken bones as a result of an accident. . . . Jim knows the benefits of hemp-based products firsthand,…

Continue Reading

ThursdaySep 19, 2019 1:50 pm

CBDNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Developing Robust Retail Network for CBD Products

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), a public cannabis company developing brands that focus on plant-based wellness and health products, is expanding the reach of its assorted CBD products to retailers throughout the United States and in legal cannabis markets. An article discussing the company reads, “At the beginning of 2019, Wildflower initiated a strategic New York expansion, making its products available in over 20 health and wellness stores throughout Manhattan. The move was a complete success, as over 40% of Wildflower’s online sales now originate from New York. . . . The company’s expansion and effective market positioning efforts…

Continue Reading

TuesdaySep 17, 2019 10:29 am

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Partners with John Legend and Casper in Nationwide Launch of 100% Hemp CBD Product Line

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the nationwide launch of its first-ever 100% hemp CBD product line. According to the update, a newly established brand partnership between PLUS and American superstar and philanthropist John Legend supports the launch, and Legend will advocate on behalf of the company’s new nationwide hemp CBD product offering. “I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they're an innovative, family-run company, and they use science to deliver a consistent,…

Continue Reading

TuesdaySep 17, 2019 9:50 am

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human CBD Study Results Published in Peer Reviewed Clinical Journal

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced the publication of final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented DehydraTECH(TM) powered TurboCBD(TM); capsules. According to the update results were published in the peer reviewed medical journal, Advances in Therapy, which focuses on clinical medicine and pharmaceutical research and has been published continually since 1984. Lexaria reported several key findings highlighted in the publication, including but not limited to: CBD in-plasma levels with the 90mg dose of TurboCBD were significantly higher than with the generic…

Continue Reading